http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105717205-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-027 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 |
| filingDate | 2016-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105717205-B |
| titleOfInvention | Metabolic marker for diagnosing stable angina pectoris |
| abstract | The invention discloses metabolic markers for diagnosing stable angina pectoris, comprising one or more of phosphorylcholine, palmitoylethanolamide, lysophosphatidylcholine (16:0), lysophosphatidylcholine (18:2), lysophosphatidylcholine (18:1), phosphatidylinositol (20:4/0: 0). When the single patient is used for diagnosing and distinguishing patients with stable angina and normal coronary arteries, the area under the ROC curve (AUC) is more than 0.7, and the clinical diagnosis significance is achieved; when the combination is used for diagnosis, the AUC is further improved along with the increase of the number of the combination, the AUC is the highest when all 6 combinations are combined, the AUC reaches 0.988, and the sensitivity and the specificity are respectively 98.3 percent and 99.2 percent under the optimal cutoff value. The metabolic marker provided by the invention can accurately diagnose stable angina pectoris, and has high accuracy and strong sensitivity and specificity. |
| priorityDate | 2016-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.